BioNexus Gene Lab (BGLC) Accumulated Expenses (2024 - 2026)

BioNexus Gene Lab's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $108552.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses changed N/A year-over-year to $108552.0; the TTM figure through Mar 2026 stood at $108552.0 (changed N/A YoY), while the FY2025 annual figure was $126036.0, down 25.31% from the prior year.
• Accumulated Expenses came in at $108552.0 for Q1 2026 at BioNexus Gene Lab, down from $126036.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $168752.0 in Q4 2024 to a low of $108552.0 in Q1 2026.
• A 3-year average of $134446.7 and a median of $126036.0 in 2025 frame the typical range for Accumulated Expenses.
• On a YoY basis, Accumulated Expenses climbed as much as 25.31% in 2025 and fell as far as 25.31% in 2025.
• BioNexus Gene Lab's Accumulated Expenses stood at $168752.0 in 2024, then slipped by 25.31% to $126036.0 in 2025, then dropped by 13.87% to $108552.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $108552.0, $126036.0, and $168752.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison